Loss of Caveolin-1 Alters Extracellular Matrix Protein Expression and Ductal Architecture in Murine Mammary Glands

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Feb 11

PMID 28187162

Citations 6

Authors

Christopher Thompson

Sahar Rahim

Jeremiah Arnold

Abigail Hielscher

Affiliations

Soon will be listed here.

Abstract

The extracellular matrix (ECM) is abnormal in breast tumors and has been reported to contribute to breast tumor progression. One factor, which may drive ongoing matrix synthesis in breast tumors, is the loss of stromal caveolin-1 (cav-1), a scaffolding protein of caveolae, which has been linked to breast tumor aggressiveness. To determine whether loss of cav-1 results in the abnormal expression of matrix proteins, mammary glands from cav- 1-/- and cav- 1 +/+ mice were investigated for differences in expression of several ECM proteins. In addition, the presence of myofibroblasts, changes in the vessel density, and differences in duct number and size were assessed in the mammary glands of both animal models. Using immunohistochemistry, expression of fibronectin, tenascin-C, collagens and αSMA were significantly increased in the mammary glands of cav-1-/- mice. Second harmonic generation revealed more organized collagen fibers in cav-1 -/- glands and supported immunohistochemical analyses of increased collagen abundance in the glands of cav-1 -/- mice. Analysis of the ductal structure demonstrated a significant increase in the number of proliferating ducts in addition to significant increases in the duct circumference and area in cav-1 -/- glands compared to cav- 1 +/+ glands. Differences in microvessel density weren't apparent between the animal models. In summary, we found that the loss of cav-1 resulted in increased ECM and α-SMA protein expression in murine mammary glands. Furthermore, we found that an abnormal ductal architecture accompanied the loss of cav-1. These data support a role for cav-1 in maintaining mammary gland structure.

Citing Articles

Involvement of adhesins (EcpD, FdeC, FimH) expressed in mammary pathogenic Escherichia coli on adhesion to bovine mammary epithelial cells.

Tsugami Y, Iwata T, Sugiyama A, Onishi M, Nakajima K, Osaki M Antonie Van Leeuwenhoek. 2024; 118(1):14.

PMID: 39361215 DOI: 10.1007/s10482-024-02025-0.

Cathepsin B Localizes in the Caveolae and Participates in the Proteolytic Cascade in Trabecular Meshwork Cells. Potential New Drug Target for the Treatment of Glaucoma.

Nettesheim A, Shim M, Dixon A, Raychaudhuri U, Gong H, Liton P J Clin Med. 2020; 10(1).

PMID: 33379277 PMC: 7795952. DOI: 10.3390/jcm10010078.

3D mapping of native extracellular matrix reveals cellular responses to the microenvironment.

Lansky Z, Mutsafi Y, Houben L, Ilani T, Armony G, Wolf S J Struct Biol X. 2020; 1:100002.

PMID: 32055794 PMC: 7001979. DOI: 10.1016/j.yjsbx.2018.100002.

Different Role of Caveolin-1 Gene in the Progression of Gynecological Tumors.

Gong Y, Yang Y, Tian S, Chen H Asian Pac J Cancer Prev. 2019; 20(11):3259-3268.

PMID: 31759347 PMC: 7062999. DOI: 10.31557/APJCP.2019.20.11.3259.

Cells respond to deletion of CAV1 by increasing synthesis of extracellular matrix.

Mendoza-Topaz C, Nelson G, Howard G, Hafner S, Rademacher P, Frick M PLoS One. 2018; 13(10):e0205306.

PMID: 30346954 PMC: 6197626. DOI: 10.1371/journal.pone.0205306.

References

Hocking D, Kowalski K . A cryptic fragment from fibronectin's III1 module localizes to lipid rafts and stimulates cell growth and contractility. J Cell Biol. 2002; 158(1):175-84. PMC: 2173025. DOI: 10.1083/jcb.200112031. View

Okamoto T, Schlegel A, Scherer P, Lisanti M . Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem. 1998; 273(10):5419-22. DOI: 10.1074/jbc.273.10.5419. View

Lisanti M, Scherer P, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu Y . Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol. 1994; 126(1):111-26. PMC: 2120102. DOI: 10.1083/jcb.126.1.111. View

Boyd N, Lockwood G, Byng J, Tritchler D, Yaffe M . Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998; 7(12):1133-44. View

Sotgia F, Del Galdo F, Casimiro M, Bonuccelli G, Mercier I, Whitaker-Menezes D . Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts. Am J Pathol. 2009; 174(3):746-61. PMC: 2665737. DOI: 10.2353/ajpath.2009.080658. View

Fraley S, Wu P, He L, Feng Y, Krisnamurthy R, Longmore G . Three-dimensional matrix fiber alignment modulates cell migration and MT1-MMP utility by spatially and temporally directing protrusions. Sci Rep. 2015; 5:14580. PMC: 4589685. DOI: 10.1038/srep14580. View

Pontiggia O, Sampayo R, Raffo D, Motter A, Xu R, Bissell M . The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin. Breast Cancer Res Treat. 2011; 133(2):459-71. PMC: 3719875. DOI: 10.1007/s10549-011-1766-x. View

Sottile J, Chandler J . Fibronectin matrix turnover occurs through a caveolin-1-dependent process. Mol Biol Cell. 2004; 16(2):757-68. PMC: 545909. DOI: 10.1091/mbc.e04-08-0672. View

Ramaswamy S, Ross K, Lander E, Golub T . A molecular signature of metastasis in primary solid tumors. Nat Genet. 2002; 33(1):49-54. DOI: 10.1038/ng1060. View

10.

Kakkad S, Solaiyappan M, Argani P, Sukumar S, Jacobs L, Leibfritz D . Collagen I fiber density increases in lymph node positive breast cancers: pilot study. J Biomed Opt. 2012; 17(11):116017. PMC: 3486274. DOI: 10.1117/1.JBO.17.11.116017. View

11.

Simpkins S, Hanby A, Holliday D, Speirs V . Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts. J Pathol. 2012; 227(4):490-8. DOI: 10.1002/path.4034. View

12.

Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L . The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev. 2005; 14(2):343-9. DOI: 10.1158/1055-9965.EPI-04-0490. View

13.

Boyd N, Martin L, Stone J, Greenberg C, Minkin S, Yaffe M . Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. Curr Oncol Rep. 2001; 3(4):314-21. DOI: 10.1007/s11912-001-0083-7. View

14.

Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson P . Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res. 2003; 5(5):R129-35. PMC: 314426. DOI: 10.1186/bcr622. View

15.

Cox T, Erler J . Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech. 2011; 4(2):165-78. PMC: 3046088. DOI: 10.1242/dmm.004077. View

16.

Sottile J, Hocking D . Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell. 2002; 13(10):3546-59. PMC: 129965. DOI: 10.1091/mbc.e02-01-0048. View

17.

Kalluri R, Zeisberg M . Fibroblasts in cancer. Nat Rev Cancer. 2006; 6(5):392-401. DOI: 10.1038/nrc1877. View

18.

Kobayashi Y, Yoshida S, Zhou Y, Nakama T, Ishikawa K, Arima M . Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy. Mol Vis. 2016; 22:436-45. PMC: 4859161. View

19.

Lee H, Park D, Razani B, Russell R, Pestell R, Lisanti M . Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia. Am J Pathol. 2002; 161(4):1357-69. PMC: 1867297. DOI: 10.1016/S0002-9440(10)64412-4. View

20.

Sloan E, Ciocca D, Pouliot N, Natoli A, Restall C, Henderson M . Stromal cell expression of caveolin-1 predicts outcome in breast cancer. Am J Pathol. 2009; 174(6):2035-43. PMC: 2684169. DOI: 10.2353/ajpath.2009.080924. View